Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.

Crypto news today is turning toward AlphaPepe after the project announced that its presale has crossed the $1.18 million ...

The trial enrolled 88 patients with biopsy-confirmed recurrent cSCC unresponsive to first-line therapy.

First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...

Q1 2026 earnings call: ficera trial updates, FDA-guided dosing study, cash runway and 2027 catalysts—read key takeaways now.

Recent updates put the utility of Summit Therapeutics's ivonescimab into question as a frontline therapy. Click here to read ...

ACAPELLA is the European multicenter clinical trial evaluating Alpha DaRT alpha-emitter radiotherapeutics combined with capecitabine for ...

First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated PMA ...

Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up ...

Alpha Tau Medical (NASDAQ:DRTS) presented early clinical results from the first three patients treated in its REGAIN study of ...

Watch this intense Ark gameplay as powerful Dinotherium mutations come to life, combining top stats, unique colors, and smart ...

Detailed price information for Alpha Teknova Inc (TKNO-Q) from The Globe and Mail including charting and trades.